Connection

Diane Havlir to Female

This is a "connection" page, showing publications Diane Havlir has written about Female.
Connection Strength

0.108
  1. Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda. PLoS One. 2018; 13(2):e0192666.
    View in: PubMed
    Score: 0.010
  2. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):e15-e18.
    View in: PubMed
    Score: 0.010
  3. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa. JAMA. 2017 Jun 06; 317(21):2196-2206.
    View in: PubMed
    Score: 0.010
  4. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One. 2014; 9(1):e84317.
    View in: PubMed
    Score: 0.008
  5. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis. 2006 Jan 01; 193(1):9-15.
    View in: PubMed
    Score: 0.004
  6. Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco. J Infect Dis. 2021 04 08; 223(7):1139-1144.
    View in: PubMed
    Score: 0.003
  7. Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020 12 01; 34(15):2328-2331.
    View in: PubMed
    Score: 0.003
  8. Evaluation of a novel community-based COVID-19 'Test-to-Care' model for low-income populations. PLoS One. 2020; 15(10):e0239400.
    View in: PubMed
    Score: 0.003
  9. Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya. J Acquir Immune Defic Syndr. 2019 12 01; 82(4):e50-e53.
    View in: PubMed
    Score: 0.003
  10. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. Lancet Infect Dis. 2019 09; 19(9):962-972.
    View in: PubMed
    Score: 0.003
  11. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda. AIDS Care. 2020 01; 32(1):119-127.
    View in: PubMed
    Score: 0.003
  12. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health. 2019 May 06; 19(1):511.
    View in: PubMed
    Score: 0.003
  13. A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome. Int J Infect Dis. 2019 Jul; 84:30-38.
    View in: PubMed
    Score: 0.003
  14. Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda. Pediatr Infect Dis J. 2018 12; 37(12):1279-1281.
    View in: PubMed
    Score: 0.003
  15. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda. Clin Infect Dis. 2018 11 28; 67(12):1853-1860.
    View in: PubMed
    Score: 0.003
  16. Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. Clin Infect Dis. 2018 09 14; 67(7):1079-1088.
    View in: PubMed
    Score: 0.003
  17. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018; 13(8):e0202990.
    View in: PubMed
    Score: 0.003
  18. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002606.
    View in: PubMed
    Score: 0.003
  19. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial. PLoS One. 2018; 13(6):e0198912.
    View in: PubMed
    Score: 0.003
  20. Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era. Clin Infect Dis. 2018 03 19; 66(7):1027-1034.
    View in: PubMed
    Score: 0.003
  21. Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz. J Infect Dis. 2018 03 05; 217(6):964-972.
    View in: PubMed
    Score: 0.003
  22. Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis. J Infect Dis. 2017 12 19; 216(12):1541-1549.
    View in: PubMed
    Score: 0.002
  23. Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda. J Infect Dis. 2017 11 15; 216(8):1008-1017.
    View in: PubMed
    Score: 0.002
  24. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am J Obstet Gynecol. 2017 12; 217(6):684.e1-684.e17.
    View in: PubMed
    Score: 0.002
  25. Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. Malar J. 2017 10 05; 16(1):400.
    View in: PubMed
    Score: 0.002
  26. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. J Int AIDS Soc. 2017 07 21; 20(Suppl 4):21673.
    View in: PubMed
    Score: 0.002
  27. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women. J Infect Dis. 2017 07 01; 216(1):29-35.
    View in: PubMed
    Score: 0.002
  28. Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda. Malar J. 2016 Aug 26; 15(1):437.
    View in: PubMed
    Score: 0.002
  29. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):128-35.
    View in: PubMed
    Score: 0.002
  30. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. J Infect Dis. 2014 Dec 15; 210(12):1938-45.
    View in: PubMed
    Score: 0.002
  31. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. J Infect Dis. 2011 Apr 01; 203(7):992-1001.
    View in: PubMed
    Score: 0.002
  32. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. J Acquir Immune Defic Syndr. 2009 Aug 01; 51(4):424-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.